Moving from opacity to transparency in pharmaceutical policy.
Dhalla
Irfan
I
Department of Medicine, St. Michael's Hospital and the University of Toronto, Toronto, Ont.
Laupacis
Andreas
A
D002170:Canada; D003365:Costs and Cost Analysis; D016527:Drug Costs / Q000639:trends*; D017723:Drug Utilization Review; D017850:Economics, Pharmaceutical / Q000458:organization & administration*; D005252:Fees, Pharmaceutical; D017408:Guidelines as Topic / Q000592:standards*; D006301:Health Services Needs and Demand / Q000639:trends*; D006801:Humans; D011050:Policy Making